|
|
Volumn 364, Issue 9442, 2004, Pages 1287-1288
|
|
Vioxx: An unequal partnership between safety and efficacy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
ETORICOXIB;
IBUPROFEN;
LUMIRACOXIB;
NAPROXEN;
PARECOXIB;
ROFECOXIB;
VALDECOXIB;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HUMAN;
MENSTRUATION;
OSTEOARTHRITIS;
PAIN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
|
|
EID: 5044233737
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(04)17198-5 Document Type: Editorial |
|
Times cited : (38)
|
|
References (0)
|